2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1144486945 M.D.
Verify on CMS →

SAMER HAFI, M.D.

Endocrinology, Diabetes & Metabolism Physician in ISSAQUAH, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 503 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
53%
generic claims · 47% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.8417/100
▼ 0 pts below national avg 83.1 · [object Object]
Industry payments
$15.91
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SAMER HAFI, M.D. is a Endocrinology, Diabetes & Metabolism Physician ([object Object]) practicing in ISSAQUAH, Washington with a Medicare Part D prescribing footprint of 5K claims across 503 beneficiaries — 47% brand-name prescribing . Their CMS MIPS Final Score of 82.8417/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $15.91 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SAMER HAFI, M.D. reported a CMS MIPS final score of 82.8417 out of 100, below the 83.1 national average, and filed 5,282 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

SAMER HAFI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

SAMER HAFI, M.D. at a glance

Near national average

NPI registry status

Active

Issued 07/31/2008

NPI 1144486945

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

5,282 100% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

82.8417/100 0.2582999999999913% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Washington

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Washington providers

Washington providers

Endocrinology, Diabetes & Metabolism Physician share within Washington

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Washington

Medicare quality performance — MIPS

SAMER HAFI, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Near national average
MIPS Final Score
82.8417/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 82.8417/100 vs national avg 83.1

0%100%National avg83%82.8%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 82.8417/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SAMER HAFI, M.D. is a Endocrinology, Diabetes & Metabolism Physician provider practicing in ISSAQUAH, Washington, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1144486945. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SAMER HAFI, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 751 NE BLAKELY DR STE 5010, ISSAQUAH, WA, 98029, with a listed phone of (425) 313-7757. NPI 1144486945 was issued on 07/31/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HAFI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,282 prescription claims written by this provider, covering 503 Medicare beneficiaries and totaling roughly $2.5 million in drug spend, split 47% brand-name and 53% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.8417/100 for the 2023 performance year (Quality 82.1476, Cost 60.658), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

751 NE BLAKELY DR STE 5010
ISSAQUAH, WA 98029

Provider Details

NPI 1144486945
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Male
NPI Issued 07/31/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.8417
Final Score
Avg: 83.1
82.1476
Quality
60.658
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where SAMER HAFI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

SWEDISH HEALTH SERVICES
ISSAQUAH, WA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SAMER HAFI, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$16

Largest payer

SANOFI-AVENTIS U.S. LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Washington WMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to SAMER HAFI, M.D.. To verify SAMER HAFI, M.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases

WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

SAMER HAFI, M.D. — brand share 47.0%
Specialty average (est.)

47% brand-name claims vs 53% generic, on 5,282 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,282
Total Claims
$2.5M
Total Drug Cost
503
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
11,134
Total Day Supply
330,790
Brand vs Generic
47% brand / 53% generic
Brand Drug Cost
$2.3M
Generic Drug Cost
$96K

Patient Demographics

Average Patient Age
72.0 years
Avg HCC Risk Score
1.52
Gender Split
56% female / 44% male
Age Distribution
<65: 54, 65-74: 250, 75-84: 164, 85+: 35

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Repaglinide
516
Ozempic
Semaglutide
479
Levothyroxine Sodium
421
Metformin Hcl Er
Metformin Hcl
357
Jardiance
Empagliflozin
295
Metformin Hcl
229
Acarbose
199
Methimazole
139
Liothyronine Sodium
126
Humalog Kwikpen U-100
Insulin Lispro
109

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How SAMER HAFI, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

SAMER HAFI, M.D.'s 5,282 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Washington

Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as HAFI.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SAMER HAFI, M.D.'s specialty?
SAMER HAFI, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in ISSAQUAH, Washington. Credentials: M.D..
How much does SAMER HAFI, M.D. prescribe under Medicare Part D?
In 2023, SAMER HAFI, M.D. wrote 5,282 Medicare Part D claims totaling $2.5M in drug costs for 503 beneficiaries.
What is SAMER HAFI, M.D.'s Medicare quality score?
SAMER HAFI, M.D. has a CMS MIPS Final Score of 82.8417/100 (Quality: 82.1476, Cost: 60.658). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SAMER HAFI, M.D. located?
SAMER HAFI, M.D. is located at 751 NE BLAKELY DR STE 5010, ISSAQUAH, WA, 98029. Phone: (425) 313-7757.
What is SAMER HAFI, M.D.'s NPI number?
SAMER HAFI, M.D.'s National Provider Identifier (NPI) is 1144486945, issued on 07/31/2008.
Does SAMER HAFI, M.D. prescribe more brand-name or generic drugs?
SAMER HAFI, M.D.'s prescribing is 47% brand-name and 53% generic drugs by claim count, with $2.3M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does SAMER HAFI, M.D. prescribe most often?
Based on 2023 Medicare Part D data, SAMER HAFI, M.D.'s most frequently prescribed drugs include Repaglinide, Ozempic, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SAMER HAFI, M.D. accept Medicare?
SAMER HAFI, M.D. appears in CMS Medicare data with 5,282 Part D claims and 503 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SAMER HAFI, M.D.'s credentials?
SAMER HAFI, M.D.'s NPI is 1144486945 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology